[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100409500":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":20,"locations":26,"responsibleParty":40,"collaborators":7,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":7,"enrollmentInfo":50,"targetDuration":53,"studyType":54,"phases":7,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Imperial College London","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"GENETIC","Research genetic analysis","Genetic analysis of DNA extracted from saliva. Participants can opt in to receive individual results of research genetic analysis for a predefined panel of clinically actionable cardiomyopathy genes.",[14,17],{"name":15,"affiliation":5,"role":16},"James Ware","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":5,"role":19},"Angharad Roberts","STUDY_DIRECTOR",[21],{"name":22,"role":23,"phone":24,"phoneExt":7,"email":25},"Rachel Buchan, MD PhD","CONTACT","0 207 351 8144","info@thehearthive.org",[27],{"facility":5,"status":28,"city":29,"state":7,"zip":7,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"RECRUITING","London","United Kingdom",{"type":32,"coordinates":33},"Point",[34,35],-0.12574,51.50853,{"lat":35,"lon":34},[38],{"name":39,"role":23,"phone":7,"phoneExt":7,"email":25},"Rachel Buchan, MSc",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100409500",false,"NCT04612296","The Heart Hive - Cardiomyopathy Study","A Longitudinal Observational Study of Self-reported Cardiomyopathy in the Heart Hive","Inclusion Criteria:\n\n* Adult (age 18 and over),\n* Males and Females,\n* Capacity to provide informed consent,\n* Patients with a confirmed diagnosis of cardiomyopathy or myocarditis,\n* People with a family history of cardiomyopathy confirmed in a first or second degree relative.\n\nNote: Pregnant women are eligible. This study is observational and entirely separate from clinical care.\n\nExclusion criteria:\n\n* Patients who lack capacity to consent for themselves,\n* Vulnerable groups (e.g. those under 18, prisoners, those in a dependent relationship, the mentally ill).\n* Patients with a confirmed history of coronary artery disease:\n* who have been informed by their treating physician that their cardiomyopathy is secondary to their coronary artery disease, or\n* who have undergone previous percutaneous coronary intervention or coronary bypass surgery\n* History of primary valvular heart disease or congenital heart disease\n* Severe, untreated or untreatable hypertension (systolic blood pressures routinely \\>180 mm Hg and\u002For diastolic blood pressures \\>120 mm Hg)","ALL","18 Years",{"count":51,"type":52},10000,"ESTIMATED","50 Years","OBSERVATIONAL","This is an online registry and database of patients with cardiomyopathy and myocarditis, coupled with an observational study of cardiomyopathies.",[57,58],"Cardiomyopathies","Myocarditis",[60,61,62,63,64],"Takotsubo","Dilated cardiomyopathy","hypertrophic cardiomyopathy","ARVC","ACM","2026-03-24",{"date":67,"type":68},"2026-03-27","ACTUAL",{"date":70,"type":68},"2019-11-09",{"date":72,"type":52},"2027-09",{"name":5,"class":6},1]